RU92016234A - DERIVATIVES 3 (2H) -PYRIDAZINONE, METHOD FOR THEIR PRODUCTION, USE, PHARMACEUTICAL COMPOSITION, METHOD - Google Patents

DERIVATIVES 3 (2H) -PYRIDAZINONE, METHOD FOR THEIR PRODUCTION, USE, PHARMACEUTICAL COMPOSITION, METHOD

Info

Publication number
RU92016234A
RU92016234A RU92016234/04A RU92016234A RU92016234A RU 92016234 A RU92016234 A RU 92016234A RU 92016234/04 A RU92016234/04 A RU 92016234/04A RU 92016234 A RU92016234 A RU 92016234A RU 92016234 A RU92016234 A RU 92016234A
Authority
RU
Russia
Prior art keywords
group
optionally
alkyl
substituent
hydrogen
Prior art date
Application number
RU92016234/04A
Other languages
Russian (ru)
Other versions
RU2130019C1 (en
Inventor
Матюш Петер
Цако Клара
Варга Ильдико
Йеднакович Андреа
Папп Агнеш
Боди Илона
Раблоцкий Дьердь
Варро Андраш
Яслиц Ласло
Миклош Анико
Левай Луца
Шмидт Дьердь
Фекете Мартон
Керти Мария
Семерейди Каталин
Зара Эржебет
Original Assignee
Эгиш Дьедьсердьяр
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU914057A external-priority patent/HU214320B/en
Application filed by Эгиш Дьедьсердьяр filed Critical Эгиш Дьедьсердьяр
Publication of RU92016234A publication Critical patent/RU92016234A/en
Application granted granted Critical
Publication of RU2130019C1 publication Critical patent/RU2130019C1/en

Links

Claims (1)

Предполагаемое изобретение относится к рацемическим или оптически активным новым производным 3(2H)-пиридазинона, к способу получения их, к фармацевтическим композициям, включающим эти соединения, к использованию указанных производных 3(2H)-пиридазинона для лечения заболеваний и для приготовления фармацевтических композиций, пригодных для лечения болезней. Новые производные 3(2H) - пиридазинона настоящего изобретения соответствуют общей формуле (I)
Figure 00000001

где R1 представляет водород, фенил, метил, необязательно имеющий бензилокси-заместитель, C1-C4-алкил, необязательно имеющий заместитель формулы R8R9N-, в которой R8 и R9 являются независимо C1-C4-алкилом, или R8 и R9 образуют вместе с примыкающим атомом азота 6-членную гетероциклическую группу, необязательно содержащую атом кислорода, или группу формулы R1 0N-, где R1 0 обозначает C1-C4-алкил, необязательно имеющий фенокси-заместитель, или C3-C5- алкенил, имеющий фенильный заместитель, кроме того, указанный C1-C4-алкил, необязательно замещается фенилом, имеющим метокси- или метансульфониламино-заместитель, или C3-C5-алкенил, необязательно имеющий галоген или галогенфенильный заместители. А и В обозначают водород, галоген или группу общей формулы (II),
Figure 00000002

где R2 и R3 независимо являются водородом или C1-C4-алкилом, или вместе с примыкающей -N-(CH2)n - группой образуют пиперазиновое или гомопиперазиновое кольцо, R4 представляет водород, C1-C4-алкил или фенил, R5, R6 и R7 каждый обозначает водород, C1-C4-алкокси -или аминогруппу, необязательно имеющую метансульфонильный заместитель, X является простой валентной связью, атомом кислорода или группой формулы -CH=CH-, m является 0 или 1, n является 2 или 3, при условии, что А и В являются всегда различными, и, если один из А и В является водородом или галогеном, другой обозначает группу формулы (II) и их аддитивные соли кислоты, обладают ценным антиаритмическим действием.The alleged invention relates to racemic or optically active novel 3 (2H) -pyridazinone derivatives, to a method for preparing them, to pharmaceutical compositions comprising these compounds, to using said 3 (2H) -pyridazinone derivatives for treating diseases and for preparing pharmaceutical compositions suitable for the treatment of diseases. New derivatives of 3 (2H) - pyridazinone of the present invention correspond to the General formula (I)
Figure 00000001

where R 1 is hydrogen, phenyl, methyl, optionally having a benzyloxy substituent, C 1 -C 4 alkyl, optionally having a substituent of the formula R 8 R 9 N-, in which R 8 and R 9 are independently C 1 -C 4 - alkyl, or R 8 and R 9 form together with the adjacent nitrogen atom a 6-membered heterocyclic group, optionally containing an oxygen atom, or a group of the formula R 1 0 N-, where R 1 0 means C 1 -C 4 alkyl, optionally having phenoxy substituent, or C 3 -C 5 - alkenyl group having a phenyl substituent, in addition, said C 1 -C 4 alkyl optionally substituted with Fe yl having methoxy or methanesulfonylamino substituent, or C 3 -C 5 -alkenyl, optionally having a halogen or halophenyl substituents. A and B represent hydrogen, halogen or a group of the general formula (II),
Figure 00000002

where R 2 and R 3 are independently hydrogen or C 1 -C 4 -alkyl, or together with the adjacent -N- (CH 2 ) n - group form a piperazine or homopiperazine ring, R 4 is hydrogen, C 1 -C 4 -alkyl or phenyl, R 5 , R 6 and R 7 each denotes hydrogen, a C 1 -C 4 alkoxy-or amino group, optionally having a methanesulfonyl substituent, X is a simple valence bond, an oxygen atom or a group of the formula -CH = CH-, m is 0 or 1, n is 2 or 3, provided that A and B are always different, and if one of A and B is hydrogen or halogen, the other Second is a group of formula (II) and their acid addition salts possess valuable antiarrhythmic effect.
RU92016234A 1991-12-20 1992-12-18 Derivatives of 3(2)-pyridazinone, a pharmaceutical composition, a method of treatment RU2130019C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU4057/91 1991-12-20
HU914057A HU214320B (en) 1991-12-20 1991-12-20 Process for producing novel 3(2h)-pyridazinon derivatives and pharmaceutical compositions producing them

Publications (2)

Publication Number Publication Date
RU92016234A true RU92016234A (en) 1995-03-27
RU2130019C1 RU2130019C1 (en) 1999-05-10

Family

ID=10966710

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92016234A RU2130019C1 (en) 1991-12-20 1992-12-18 Derivatives of 3(2)-pyridazinone, a pharmaceutical composition, a method of treatment

Country Status (22)

Country Link
US (1) US5395934A (en)
JP (1) JP3165935B2 (en)
KR (1) KR100234596B1 (en)
CN (1) CN1088578A (en)
AT (1) AT403282B (en)
BE (1) BE1006223A4 (en)
CA (1) CA2085796C (en)
CH (1) CH684754A5 (en)
CZ (1) CZ286039B6 (en)
DE (1) DE4243381B4 (en)
DK (1) DK152892A (en)
ES (1) ES2108595B1 (en)
FI (1) FI106374B (en)
FR (1) FR2685329B1 (en)
GB (1) GB2262526B (en)
GR (1) GR1002281B (en)
HU (1) HU214320B (en)
NL (1) NL194966C (en)
PL (1) PL172933B1 (en)
RU (1) RU2130019C1 (en)
YU (1) YU48973B (en)
ZA (1) ZA929903B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935945A (en) * 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5969017A (en) * 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
CA2334220A1 (en) 1998-06-05 1999-12-16 Egis Gyogyszergyar Rt. Process for the preparation of a 3(2h)-pyridazinone- 4-substituted amino- 5-chloro- derivative
ES2162731B1 (en) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ NEW ARILPIPERACILNILALQUIL-3 (2H) -PIRIDACINONAS.
AU1592301A (en) * 1999-11-11 2001-06-06 Fred Hutchinson Cancer Research Center Novel topoisomerase poisons for the treatment of proliferative disorders
US7173063B1 (en) 2000-11-10 2007-02-06 Fred Hutchinson Cancer Research Center Topoisomerase poisons for the treatment of proliferative disorders
HUP0103064A3 (en) * 2001-07-26 2005-06-28 Egis Gyogyszergyar Nyilvanosan Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
CA2474239A1 (en) * 2002-01-18 2003-07-24 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
HU227181B1 (en) * 2002-09-11 2010-09-28 Egis Gyogyszergyar Nyilvanosan Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxyphenyl)ethyl)]-n-methylamino]-propylamino]-3-(2h)-pyridazinone for producing pharmaceutical compositions having metabolic modulator effect
WO2011062437A2 (en) 2009-11-20 2011-05-26 에스케이케미칼주식회사 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
CA2789151A1 (en) * 2010-02-08 2011-08-11 Allergan, Inc. Pyridazine derivatives useful as cannabinoid-2 agonists
FR2969606B1 (en) * 2010-12-22 2013-01-11 Pf Medicament DERIVATIVES OF DIARYLPYRIDAZINONES, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPEUTICS
RU2455004C1 (en) * 2011-04-01 2012-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" (ФГБОУ ВПО "ЯГТУ") Method for producing sulphochlorides of 6-arylpyridazine-3(2h)-ones

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1285235A (en) * 1960-01-21 1962-02-23 Ciba Geigy Process for the preparation of new diazines, in particular of 1-aryl-3-r-5-r'pyridazones- (6) in which r represents an aliphatically etherified hydroxyl and r 'represents an n- (beta-aryl-ethyl) - group piperazino
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
DE3048487A1 (en) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt BASICLY SUBSTITUTED PYRIDAZINE, THEIR PRODUCTION AND THEIR USE
JPH0641454B2 (en) * 1985-02-27 1994-06-01 日産化学工業株式会社 Pyridazinone derivative
US4892947A (en) * 1985-04-27 1990-01-09 Nissan Chemical Industries Ltd. 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it
US4992433A (en) * 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
MY104343A (en) * 1987-11-23 1994-03-31 Janssen Pharmaceutica Nv Novel pyridizinamine deravatives
US4992243A (en) * 1988-03-17 1991-02-12 Fedin Marat A Method of sterilizing anthers
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
DE3902316A1 (en) * 1989-01-26 1990-08-02 Lentia Gmbh Novel piperazinylalkyl-3(2H)-pyridazinones, process for their preparation and their use as hypotensive agents

Similar Documents

Publication Publication Date Title
RU92016234A (en) DERIVATIVES 3 (2H) -PYRIDAZINONE, METHOD FOR THEIR PRODUCTION, USE, PHARMACEUTICAL COMPOSITION, METHOD
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
EP0343900A3 (en) Piperazine compounds
ATE152445T1 (en) 3,5-DIOXO-(2H,4H)-1,2,4-TRIAZINE AS 5HT1A LIGAND
DE3873612D1 (en) DITHIOACETAL COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
ES482134A1 (en) 1-(3-Mercapto-2-methylpropanoyl)prolyl amino acid derivatives and salts thereof, processes for their preparation, and pharmaceutical compositions containing such compounds.
EP0353955A3 (en) Novel compounds
EP0309422A3 (en) New amidino tricycle derivatives
CA2085796A1 (en) 3(2h)-pyridazinone derivatives and process for the preparation thereof
SE8406302L (en) NEW AMINOGUANIDE DERIVATIVES AND A PROCEDURE FOR THEIR PREPARATION
RU96115333A (en) SUBSTITUTED GUANIDIDES OF BORNIC ACID, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD OF ITS RECEPTION, METHOD OF TREATMENT
DK476387A (en) NAPHTHEL DERIVATIVES AND MEDICINES CONTAINING SUCH COMPOUNDS
ATE24503T1 (en) PHENYLPIPERAZINE DERIVATIVES AND PROCESS FOR THEIR MANUFACTURE.
JPS5283396A (en) Novel compound physiologically acceptable salts thereof process for preparing same and medical composition containing same
ES8301196A1 (en) Cinnamoyl-cinnamic acid derivative, its preparation and its use as a therapeutic agent.
DE3769451D1 (en) INDAN DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THE INTERIM PRODUCTS OBTAINED, THEIR USE AS MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THE SAME.
PT83786A (en) NEW BASIC SUBSTITUTED PYRIDINE COMPOUNDS METHOD FOR THE PRODUCTION THEREOF THE MEDICAMENT CONTAINING THEY AND THEIR USE
DE3572808D1 (en) 4-(nitrophenyl)-tetrahydropyridines, process for their preparation and their application as pharmaceutical compounds
ES464013A1 (en) Substituted omicron-phenylenediamine derivatives, process for their preparation and their use as medicaments
ES469455A1 (en) Novel O-propyloximes
BE879727A (en) 1,2,4-TRIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE
ATE22683T1 (en) SUBSTITUTE HETEROCYCLYLPHENYLSULPHONYL AND PHOSPHONYLAMIDINE, PROCESS FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL APPLICATION.
RU93041059A (en) 1-AZABITSIKLOALKAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, THEIR CONTAINING, AND METHOD OF THEIR OBTAINING
RU97102159A (en) ETIOLOGY OF SCHIZOPHRENIA AND PARKINSON'S DISEASE